Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord Injury

NCT05018793 Phase 1 RECRUITING

This trial will study the safety and efficacy of intrathecal injection of cultured autologous adult adipose derived mesenchymal stem cells versus cultured allogeneic adult umbilical-cord derived mesenchymal stem cells for the treatment of spinal cord injury

Details

Lead sponsor	The Foundation for Orthopaedics and Regenerative Medicine
Phase	Phase 1
Status	RECRUITING
Enrolment	15
Start date	2024-12-01
Completion	2028-12

Conditions

• Spinal Cord Injuries

Interventions

• autologous adipose derived mesenchymal stem cells
• AlloRx

Primary outcomes

• Safety (adverse events) — Four year follow-up
  Clinical monitoring of possible adverse events or complications

Countries

Antigua and Barbuda, Greece